The RiptideRx waitlist

Stay in the current.

Consultations are opening state by state. Tell us where you are and we’ll email you when a licensed clinician is available there.

Step 1 of 3

What would you like to discuss?

Choose one. Your clinician may suggest something different, or nothing at all.

SemaglutideFDA-approved as Ozempic, Rybelsus and Wegovy for type 2 diabetes and chronic weight management, among other indications.TirzepatideFDA-approved as Mounjaro and Zepbound for type 2 diabetes and chronic weight management, among other indications.PT-141 (Bremelanotide)Bremelanotide (Vyleesi) is FDA-approved to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women; it is not approved for men or postmenopausal women.GHK-CuCompounded · topical · not FDA-approvedSermorelinCompounded · not FDA-approvedTesamorelinTesamorelin (Egrifta, Egrifta SV and Egrifta WR) is FDA-approved to reduce excess abdominal visceral fat in adults with HIV who have lipodystrophy; it is not approved for general weight loss.

Compare treatments

Stay in the current.

You’re on the list.